David A. Siegel Certara, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Certara, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 64,500 shares of CERT stock, worth $615,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,500

Previous 18,900 241.27%

Holding current value

$615,975

Previous $261,000 189.27%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.46 - $16.58 $476,976 - $756,047	45,600 Added 241.27%	64,500 $755,000
Q2 2024 Aug 14, 2024	SELL	$13.36 - $18.94 $140,280 - $198,870	-10,500 Reduced 35.71%	18,900 $261,000
Q1 2024 May 15, 2024	SELL	$15.65 - $19.45 $258,225 - $320,925	-16,500 Reduced 35.95%	29,400 $525,000
Q4 2023 Feb 14, 2024	SELL	$12.12 - $18.19 $41,208 - $61,846	-3,400 Reduced 6.9%	45,900 $807,000
Q3 2023 Nov 14, 2023	SELL	$13.9 - $19.58 $148,730 - $209,505	-10,700 Reduced 17.83%	49,300 $716,000
Q2 2023 Aug 14, 2023	BUY	$16.89 - $24.64 $687,423 - $1 Million	40,700 Added 210.88%	60,000 $1.09 Million
Q1 2023 May 15, 2023	SELL	$15.9 - $24.72 $327,540 - $509,232	-20,600 Reduced 51.63%	19,300 $465,000
Q4 2022 Feb 14, 2023	SELL	$10.7 - $17.84 $306,020 - $510,224	-28,600 Reduced 41.75%	39,900 $641,000
Q3 2022 Nov 14, 2022	BUY	$12.84 - $24.13 $739,584 - $1.39 Million	57,600 Added 528.44%	68,500 $910,000
Q2 2022 Aug 15, 2022	SELL	$16.75 - $22.54 $35,175 - $47,334	-2,100 Reduced 16.15%	10,900 $234,000
Q1 2022 May 16, 2022	BUY	$17.89 - $28.73 $71,560 - $114,920	4,000 Added 44.44%	13,000 $279,000
Q4 2021 Feb 14, 2022	BUY	$26.1 - $45.21 $234,900 - $406,890	9,000 New	9,000 $256,000

Others Institutions Holding CERT

# of Institutions

234

Shares Held

106M

Call Options Held

26.4K

Put Options Held

19.2K

View Full List

About Certara, Inc.

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.53B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

More about CERT

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account